News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sideris Pharmaceuticals Appoints Gregory I. Berk, M.D., As President And Chief Medical Officer



1/8/2014 7:49:10 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Sideris Pharmaceuticals, Inc., a biotechnology company developing therapeutics for the treatment of transfusional iron overload diseases, today announced the appointment of Gregory I. Berk, M.D., as its President and Chief Medical Officer. As the Company’s most senior operating executive, he will also join its Board of Directors. Dr. Berk assumes the role of President of Sideris as the company is rapidly advancing its lead product candidate, SP-420, into human clinical trials for iron overload diseases.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES